Literature DB >> 15610683

The influence of aging on the early detection, diagnosis, and treatment of breast cancer.

Marisa F Siebel1, Hyman B Muss.   

Abstract

Patterns of care for women with breast cancer vary substantially with patient age. Older patients with breast cancer frequently receive less than standard management, resulting in poorer outcome. At diagnosis, the health status of older women with breast cancer affects survival and treatment decisions. Age-related comorbidity may limit diagnostic tests, narrow treatment options, and significantly increase mortality not related to breast cancer. Yet, for healthy older women with early-stage breast cancer, stage-adjusted survival is similar to that of younger women. Calendar age is not sufficient to encompass the heterogeneity in health status of the elderly. Instead, management of older women with breast cancer should be based on anticipated survival, functional status, and the goals of the patient for treatment. In this review, we evaluate pertinent data and provide guidance for the management of older women with breast cancer.

Entities:  

Mesh:

Year:  2005        PMID: 15610683     DOI: 10.1007/s11912-005-0022-0

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


  59 in total

1.  Patterns of use of chemotherapy for breast cancer in older women: findings from Medicare claims data.

Authors:  X Du; J S Goodwin
Journal:  J Clin Oncol       Date:  2001-03-01       Impact factor: 44.544

2.  Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1- and/or ErbB-2-positive, estrogen receptor-positive primary breast cancer: evidence from a phase III randomized trial.

Authors:  M J Ellis; A Coop; B Singh; L Mauriac; A Llombert-Cussac; F Jänicke; W R Miller; D B Evans; M Dugan; C Brady; E Quebe-Fehling; M Borgs
Journal:  J Clin Oncol       Date:  2001-09-15       Impact factor: 44.544

3.  Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older.

Authors:  R Yancik; M N Wesley; L A Ries; R J Havlik; B K Edwards; J W Yates
Journal:  JAMA       Date:  2001-02-21       Impact factor: 56.272

4.  How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials.

Authors:  Warren B Sateren; Edward L Trimble; Jeffrey Abrams; Otis Brawley; Nancy Breen; Leslie Ford; Mary McCabe; Richard Kaplan; Malcolm Smith; Richard Ungerleider; Michaele C Christian
Journal:  J Clin Oncol       Date:  2002-04-15       Impact factor: 44.544

5.  Costs of treatment for elderly women with early-stage breast cancer in fee-for-service settings.

Authors:  Joan L Warren; Martin L Brown; Michael P Fay; Nicola Schussler; Arnold L Potosky; Gerald F Riley
Journal:  J Clin Oncol       Date:  2002-01-01       Impact factor: 44.544

6.  Representation of older patients in cancer treatment trials.

Authors:  E L Trimble; C L Carter; D Cain; B Freidlin; R S Ungerleider; M A Friedman
Journal:  Cancer       Date:  1994-10-01       Impact factor: 6.860

7.  Safety and efficacy of weekly docetaxel in frail and/or elderly patients with metastatic breast cancer: a phase II study.

Authors:  Randal D'hondt; Robert Paridaens; Hans Wildiers; Karen Pauwelyn; Jose Thomas; Herlinde Dumez; Allan T Van Oosterom
Journal:  Anticancer Drugs       Date:  2004-04       Impact factor: 2.248

8.  Combination chemotherapy versus single-agent therapy as first- and second-line treatment in metastatic breast cancer: a prospective randomized trial.

Authors:  H Joensuu; K Holli; M Heikkinen; E Suonio; A R Aro; P Hietanen; R Huovinen
Journal:  J Clin Oncol       Date:  1998-12       Impact factor: 44.544

9.  Discrepancy between consensus recommendations and actual community use of adjuvant chemotherapy in women with breast cancer.

Authors:  Xianglin L Du; Charles R Key; Cynthia Osborne; Jonathan D Mahnken; James S Goodwin
Journal:  Ann Intern Med       Date:  2003-01-21       Impact factor: 25.391

10.  Barriers to clinical trial participation by older women with breast cancer.

Authors:  M Margaret Kemeny; Bercedis L Peterson; Alice B Kornblith; Hyman B Muss; Judith Wheeler; Ellis Levine; Nancy Bartlett; Gini Fleming; Harvey J Cohen
Journal:  J Clin Oncol       Date:  2003-06-15       Impact factor: 44.544

View more
  6 in total

1.  Is Availability of Mammography Services at Federally Qualified Health Centers Associated with Breast Cancer Mortality-to-Incidence Ratios? An Ecological Analysis.

Authors:  Swann Arp Adams; Seul Ki Choi; Jan M Eberth; Daniela B Friedman; Mei Po Yip; Reginald D Tucker-Seeley; Lisa T Wigfall; James R Hébert
Journal:  J Womens Health (Larchmt)       Date:  2015-07-24       Impact factor: 2.681

2.  Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality database.

Authors:  Philippe Autier; Mathieu Boniol; Carlo La Vecchia; Carlo LaVecchia; Lars Vatten; Anna Gavin; Clarisse Héry; Mary Heanue
Journal:  BMJ       Date:  2010-08-11

3.  Disparities in use of gynecologic oncologists for women with ovarian cancer in the United States.

Authors:  Shamly Austin; Michelle Y Martin; Yongin Kim; Ellen M Funkhouser; Edward E Partridge; Maria Pisu
Journal:  Health Serv Res       Date:  2012-12-03       Impact factor: 3.402

4.  Breast cancer mortality in neighbouring European countries with different levels of screening but similar access to treatment: trend analysis of WHO mortality database.

Authors:  Philippe Autier; Mathieu Boniol; Anna Gavin; Lars J Vatten
Journal:  BMJ       Date:  2011-07-28

5.  Alter between gut bacteria and blood metabolites and the anti-tumor effects of Faecalibacterium prausnitzii in breast cancer.

Authors:  Ji Ma; Lingqi Sun; Ying Liu; Hui Ren; Yali Shen; Feng Bi; Tao Zhang; Xin Wang
Journal:  BMC Microbiol       Date:  2020-04-09       Impact factor: 3.605

6.  By invitation only - the case for breast cancer screening reminders for women over 69 years.

Authors:  Carla Saunders; Monica Robotin; Sally Crossing
Journal:  Aust New Zealand Health Policy       Date:  2008-11-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.